Research Output 2016 2019

Filter
Review article
2016
5 Citations (Scopus)

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

Hollestelle, A., van der Baan, F. H., Berchuck, A., Johnatty, S. E., Aben, K. K., Agnarsson, B. A., Aittomäki, K., Alducci, E., Andrulis, I. L., Anton-Culver, H., Antonenkova, N. N., Antoniou, A. C., Apicella, C., Arndt, V., Arnold, N., Arun, B. K., Arver, B., Ashworth, A., Baglietto, L., Balleine, R. & 31 others, Bandera, E. V., Barrowdale, D., Bean, Y. T., Beckmann, L., Beckmann, M. W., Benitez, J., Berger, A., Berger, R., Beuselinck, B., Bisogna, M., Bjorge, L., Blomqvist, C., Bogdanova, N. V., Bojesen, A., Bojesen, S. E., Bolla, M. K., Bonanni, B., Brand, J. S., Brauch, H., Brenner, H., Brinton, L., Brooks-Wilson, A., Bruinsma, F., Brunet, J., Brüning, T., Budzilowska, A., Bunker, C. H., Burwinkel, B., Butzow, R., Pedersen, I. S. & Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, and Consortium of Modifiers of BRCA1 and BRCA2, 2016, In : Gynecologic Oncology. 141, 2, p. 386-401 16 p.

Research output: Contribution to journalReview articleResearchpeer-review

Ovarian Neoplasms
Breast Neoplasms
Mutation
Survival
Genetic Testing